PNO Consultants

Call us: +44 161 488 3488.

Call us:
+44 161 488 3488
#

PNO is Europe’s largest independent
public funding advisory, annually raising
over €250 million on behalf of its clients.

PNO employs just under 250 staff
operating in 12 European countries.
In terms of core services, PNO is active
across the entire grant acquisition process.

BioTic

Modern use of industrial biotechnology (IB) holds the key to a bio-based economy. Deploying the full potential of biotech innovation will enable the European industry to deliver high-value products to consumers and create new commercial opportunities. New feedstock demands will lead to synergies amongst SMEs and large industrial partners. New technological developments will boost European export of technology and facilities by bringing Europe’s top sectors together: chemical industry, engineering and renewables.

Contact us for more info:

However to date, major hurdles continue to hamper the full exploitation of biotechnology in Europe. These hurdles may vary from technological bottlenecks to limited availability of venture capital and fragmented policy frameworks. Funded by the European Commission, BIO-TIC was launched with the aim to establish an overview of the barriers to biotech innovation and find solutions to overcome them.

Our activities

In BIO-TIC we seek to define product segments and applications that promise significant potential for Europe’s industry and society by 2030. We have now identified 5 major “bio-Business cases” which are EU-competitive and have the potential to introduce cross-cutting technology ideas. These are:

  • Bioplastics PHA and PLA
  • Building blocks
  • Biofuels
  • Biosurfactants
  • CO2-based chemicals

In addition to the business cases, we are developing three in-depth “bio-Roadmaps”. These will focus on the market potential, R&D priorities and non-technological hurdles of IB innovation. In particular, the market roadmap will provide market projections until 2030. The technology roadmap will focus on setting R&D priorities and identifying needs for pilot and demonstration of plant activities. Last but not least, the non-technological barriers roadmap will identify regulatory and non-technological hurdles that may inhibit industrial biotech innovation reaching new market opportunities. The final roadmaps will be released in July 2015.

To measure the impact of the bio-roadmaps deployment in Europe, we plan to establish a “bio-Observatory”. This is a common regulatory framework which will describe definitions, standards, data sources and processes for systematic monitoring on the market uptake of bio-based products. Our aim is to achieve consistency in the data all along the value chain.

Contact us for more info:

Follow us on Twitter PNO Consultants op social media
More PNO:

Our Team
SME Services
Large Company
Public Sector

 

Copyrights © PNO Consultants  Sitemap  |  About